View Future GrowthLinkgenesis 과거 순이익 실적과거 기준 점검 1/6Linkgenesis의 수입은 연평균 -24.7%의 비율로 감소해 온 반면, IT 산업은 수입이 연평균 8.9% 증가했습니다. 매출은 연평균 1.8%의 비율로 감소해 왔습니다. Linkgenesis의 자기자본이익률은 5.9%이고 순이익률은 16.5%입니다.핵심 정보-24.74%순이익 성장률-27.26%주당순이익(EPS) 성장률IT 산업 성장률14.11%매출 성장률-1.79%자기자본이익률5.92%순이익률16.51%최근 순이익 업데이트31 Dec 2025최근 과거 실적 업데이트Reported Earnings • Mar 18Full year 2025 earnings released: EPS: ₩249 (vs ₩38.00 loss in FY 2024)Full year 2025 results: EPS: ₩249 (up from ₩38.00 loss in FY 2024). Revenue: ₩17.0b (up 30% from FY 2024). Net income: ₩2.80b (up ₩3.23b from FY 2024). Profit margin: 17% (up from net loss in FY 2024). Over the last 3 years on average, earnings per share has fallen by 54% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.Reported Earnings • Nov 14Third quarter 2025 earnings released: EPS: ₩107 (vs ₩27.00 in 3Q 2024)Third quarter 2025 results: EPS: ₩107 (up from ₩27.00 in 3Q 2024). Revenue: ₩3.93b (up 64% from 3Q 2024). Net income: ₩1.21b (up 302% from 3Q 2024). Profit margin: 31% (up from 13% in 3Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.Reported Earnings • Aug 16Second quarter 2025 earnings released: EPS: ₩51.00 (vs ₩60.00 in 2Q 2024)Second quarter 2025 results: EPS: ₩51.00 (down from ₩60.00 in 2Q 2024). Revenue: ₩3.45b (up 1.5% from 2Q 2024). Net income: ₩576.6m (down 15% from 2Q 2024). Profit margin: 17% (down from 20% in 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 73 percentage points per year, which is a significant difference in performance.Reported Earnings • Mar 14Full year 2024 earnings released: ₩38.00 loss per share (vs ₩111 profit in FY 2023)Full year 2024 results: ₩38.00 loss per share (down from ₩111 profit in FY 2023). Revenue: ₩13.1b (down 7.7% from FY 2023). Net loss: ₩426.5m (down 134% from profit in FY 2023). Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.Reported Earnings • Aug 15Second quarter 2024 earnings released: EPS: ₩60.00 (vs ₩92.00 in 2Q 2023)Second quarter 2024 results: EPS: ₩60.00 (down from ₩92.00 in 2Q 2023). Revenue: ₩3.40b (down 20% from 2Q 2023). Net income: ₩677.8m (down 34% from 2Q 2023). Profit margin: 20% (down from 24% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings.Reported Earnings • Mar 16Full year 2023 earnings released: EPS: ₩111 (vs ₩172 in FY 2022)Full year 2023 results: EPS: ₩111 (down from ₩172 in FY 2022). Revenue: ₩14.2b (down 18% from FY 2022). Net income: ₩1.25b (down 35% from FY 2022). Profit margin: 8.8% (down from 11% in FY 2022). Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.모든 업데이트 보기Recent updatesReported Earnings • Mar 18Full year 2025 earnings released: EPS: ₩249 (vs ₩38.00 loss in FY 2024)Full year 2025 results: EPS: ₩249 (up from ₩38.00 loss in FY 2024). Revenue: ₩17.0b (up 30% from FY 2024). Net income: ₩2.80b (up ₩3.23b from FY 2024). Profit margin: 17% (up from net loss in FY 2024). Over the last 3 years on average, earnings per share has fallen by 54% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.분석 기사 • Jan 02Capital Allocation Trends At Linkgenesis (KOSDAQ:219420) Aren't IdealWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...Reported Earnings • Nov 14Third quarter 2025 earnings released: EPS: ₩107 (vs ₩27.00 in 3Q 2024)Third quarter 2025 results: EPS: ₩107 (up from ₩27.00 in 3Q 2024). Revenue: ₩3.93b (up 64% from 3Q 2024). Net income: ₩1.21b (up 302% from 3Q 2024). Profit margin: 31% (up from 13% in 3Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.Reported Earnings • Aug 16Second quarter 2025 earnings released: EPS: ₩51.00 (vs ₩60.00 in 2Q 2024)Second quarter 2025 results: EPS: ₩51.00 (down from ₩60.00 in 2Q 2024). Revenue: ₩3.45b (up 1.5% from 2Q 2024). Net income: ₩576.6m (down 15% from 2Q 2024). Profit margin: 17% (down from 20% in 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 73 percentage points per year, which is a significant difference in performance.Buy Or Sell Opportunity • Apr 14Now 24% overvaluedOver the last 90 days, the stock has fallen 9.9% to ₩5,460. The fair value is estimated to be ₩4,411, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 6.5% over the last 3 years. Meanwhile, the company became loss making.Buy Or Sell Opportunity • Mar 24Now 23% overvaluedOver the last 90 days, the stock has fallen 2.0% to ₩5,420. The fair value is estimated to be ₩4,414, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 6.5% over the last 3 years. Meanwhile, the company became loss making.Reported Earnings • Mar 14Full year 2024 earnings released: ₩38.00 loss per share (vs ₩111 profit in FY 2023)Full year 2024 results: ₩38.00 loss per share (down from ₩111 profit in FY 2023). Revenue: ₩13.1b (down 7.7% from FY 2023). Net loss: ₩426.5m (down 134% from profit in FY 2023). Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.공지 • Mar 01Linkgenesis Co., Ltd., Annual General Meeting, Mar 24, 2025Linkgenesis Co., Ltd., Annual General Meeting, Mar 24, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 401, simin-daero, dongan-gu, gyeonggi-do, anyang South KoreaBuy Or Sell Opportunity • Jan 22Now 28% undervaluedOver the last 90 days, the stock has risen 72% to ₩7,370. The fair value is estimated to be ₩10,170, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 3.1% over the last 3 years. Earnings per share has declined by 43%.분석 기사 • Jan 17Returns On Capital Signal Tricky Times Ahead For Linkgenesis (KOSDAQ:219420)If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...New Risk • Jan 16New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 14% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (14% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.1% net profit margin). Market cap is less than US$100m (₩91.6b market cap, or US$62.8m).New Risk • Dec 16New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (₩67.3b market cap, or US$46.8m).New Risk • Nov 26New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.1% net profit margin). Market cap is less than US$100m (₩67.4b market cap, or US$48.3m).Reported Earnings • Aug 15Second quarter 2024 earnings released: EPS: ₩60.00 (vs ₩92.00 in 2Q 2023)Second quarter 2024 results: EPS: ₩60.00 (down from ₩92.00 in 2Q 2023). Revenue: ₩3.40b (down 20% from 2Q 2023). Net income: ₩677.8m (down 34% from 2Q 2023). Profit margin: 20% (down from 24% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings.분석 기사 • Aug 05Linkgenesis Co., Ltd.'s (KOSDAQ:219420) 26% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatioUnfortunately for some shareholders, the Linkgenesis Co., Ltd. ( KOSDAQ:219420 ) share price has dived 26% in the last...Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to ₩4,510, the stock trades at a trailing P/E ratio of 56.3x. Average trailing P/E is 16x in the IT industry in South Korea. Total loss to shareholders of 59% over the past three years.Buy Or Sell Opportunity • May 20Now 23% undervaluedOver the last 90 days, the stock has risen 4.4% to ₩7,770. The fair value is estimated to be ₩10,065, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 2.9% over the last 3 years. Earnings per share has declined by 15%.New Risk • May 18New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 5.9% Last year net profit margin: 16% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.9% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (5.9% net profit margin). Market cap is less than US$100m (₩90.7b market cap, or US$67.0m).Valuation Update With 7 Day Price Move • Mar 21Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩8,720, the stock trades at a trailing P/E ratio of 78.2x. Average trailing P/E is 18x in the IT industry in South Korea. Total returns to shareholders of 9.8% over the past three years.Reported Earnings • Mar 16Full year 2023 earnings released: EPS: ₩111 (vs ₩172 in FY 2022)Full year 2023 results: EPS: ₩111 (down from ₩172 in FY 2022). Revenue: ₩14.2b (down 18% from FY 2022). Net income: ₩1.25b (down 35% from FY 2022). Profit margin: 8.8% (down from 11% in FY 2022). Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Feb 07Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩6,240, the stock trades at a trailing P/E ratio of 23.6x. Average trailing P/E is 20x in the IT industry in South Korea. Total loss to shareholders of 26% over the past three years.Valuation Update With 7 Day Price Move • Dec 12Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₩6,890, the stock trades at a trailing P/E ratio of 26.1x. Average trailing P/E is 24x in the IT industry in South Korea. Total loss to shareholders of 2.1% over the past three years.Valuation Update With 7 Day Price Move • Jul 26Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₩5,360, the stock trades at a trailing P/E ratio of 21.3x. Average trailing P/E is 17x in the IT industry in South Korea. Total loss to shareholders of 22% over the past three years.Reported Earnings • Mar 18Full year 2022 earnings released: EPS: ₩172 (vs ₩394 in FY 2021)Full year 2022 results: EPS: ₩172 (down from ₩394 in FY 2021). Revenue: ₩17.3b (up 7.7% from FY 2021). Net income: ₩1.93b (down 53% from FY 2021). Profit margin: 11% (down from 26% in FY 2021). Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Sep 28Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₩5,300, the stock trades at a trailing P/E ratio of 20.9x. Average trailing P/E is 16x in the IT industry in South Korea. Total loss to shareholders of 36% over the past three years.Valuation Update With 7 Day Price Move • Jun 17Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₩6,030, the stock trades at a trailing P/E ratio of 30.6x. Average trailing P/E is 15x in the IT industry in South Korea. Total loss to shareholders of 19% over the past three years.Valuation Update With 7 Day Price Move • Mar 17Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₩8,580, the stock trades at a trailing P/E ratio of 41.9x. Average trailing P/E is 18x in the IT industry in South Korea. Total returns to shareholders of 27% over the past three years.Valuation Update With 7 Day Price Move • Jul 30Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₩10,150, the stock trades at a trailing P/E ratio of 40.5x. Average trailing P/E is 25x in the IT industry in South Korea. Total returns to shareholders of 18% over the past three years.분석 기사 • Apr 07Linkgenesis (KOSDAQ:219420) Might Be Having Difficulty Using Its Capital EffectivelyDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things...Reported Earnings • Mar 17Full year 2020 earnings released: EPS ₩55.00 (vs ₩59.00 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: ₩12.9b (up 13% from FY 2019). Net income: ₩722.2m (down 1.3% from FY 2019). Profit margin: 5.6% (down from 6.4% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.분석 기사 • Mar 11Does Linkgenesis (KOSDAQ:219420) Have A Healthy Balance Sheet?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...분석 기사 • Feb 21Calculating The Fair Value Of Linkgenesis Co., Ltd. (KOSDAQ:219420)Does the February share price for Linkgenesis Co., Ltd. ( KOSDAQ:219420 ) reflect what it's really worth? Today, we...분석 기사 • Feb 05Linkgenesis Co., Ltd.'s (KOSDAQ:219420) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?Linkgenesis (KOSDAQ:219420) has had a great run on the share market with its stock up by a significant 25% over the...Is New 90 Day High Low • Feb 04New 90-day high: ₩8,620The company is up 23% from its price of ₩6,980 on 06 November 2020. The South Korean market is up 27% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the IT industry, which is up 13% over the same period.분석 기사 • Jan 21What Type Of Returns Would Linkgenesis'(KOSDAQ:219420) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?Linkgenesis Co., Ltd. ( KOSDAQ:219420 ) shareholders should be happy to see the share price up 13% in the last month...Is New 90 Day High Low • Jan 12New 90-day high: ₩8,220The company is up 2.0% from its price of ₩8,050 on 14 October 2020. The South Korean market is up 28% over the last 90 days, indicating the company underperformed over that time. It also underperformed the IT industry, which is up 18% over the same period.분석 기사 • Jan 06Here's What To Make Of Linkgenesis' (KOSDAQ:219420) Returns On CapitalWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? Typically...분석 기사 • Dec 22Here's Why We Think Linkgenesis's (KOSDAQ:219420) Statutory Earnings Might Be ConservativeAs a general rule, we think profitable companies are less risky than companies that lose money. That said, the current...분석 기사 • Dec 03Is Linkgenesis (KOSDAQ:219420) Using Too Much Debt?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...분석 기사 • Nov 18Unpleasant Surprises Could Be In Store For Linkgenesis Co., Ltd.'s (KOSDAQ:219420) SharesWith a price-to-earnings (or "P/E") ratio of 50x Linkgenesis Co., Ltd. (KOSDAQ:219420) may be sending very bearish...Reported Earnings • Nov 14Third quarter 2020 earnings released: EPS ₩59.00The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: ₩3.61b (up 78% from 3Q 2019). Net income: ₩582.5m (up ₩753.0m from 3Q 2019). Profit margin: 16% (up from net loss in 3Q 2019). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 74% per year but the company’s share price has increased by 22% per year, which means it is well ahead of earnings.매출 및 비용 세부 내역Linkgenesis가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이KOSDAQ:A219420 매출, 비용 및 순이익 (KRW Millions)날짜매출순이익일반관리비연구개발비31 Dec 2516,9752,8023,40339230 Sep 2513,6925003,552030 Jun 2512,154-4113,405031 Mar 2512,103-3103,080031 Dec 2413,104-4263,132030 Sep 2413,1311403,319030 Jun 2414,3955483,191031 Mar 2415,2279013,214031 Dec 2314,1941,2553,092030 Sep 2317,3952,9773,157-9530 Jun 2317,1613,0643,180-9531 Mar 2317,5142,8362,979-5031 Dec 2217,2681,9292,660030 Sep 2216,6652,6102,861-10630 Jun 2216,3682,8502,601-4231 Mar 2215,1752,2192,4555031 Dec 2116,0304,0962,313030 Sep 2114,5932,2771,6784830 Jun 2115,0791,8241,657-1731 Mar 2114,3302,2121,382031 Dec 2012,8777221,392030 Sep 2013,0931,3661,72415330 Jun 2011,5126131,86215331 Mar 2011,4973122,240031 Dec 1911,4057322,306030 Sep 1910,4211,5792,073030 Jun 1911,0782,3521,906031 Mar 1911,7632,6141,814031 Dec 1811,6322,2671,780030 Sep 1811,5732,3481,548030 Jun 1811,6742,4151,560031 Mar 1811,9803,2641,500031 Dec 1711,7942,7141,337030 Sep 1712,1743,4121,220030 Jun 1712,2903,1661,126031 Dec 1610,1951,7581,036031 Dec 159,0239381,1100양질의 수익: A219420는 ₩772.8M 규모의 큰 일회성 이익이 있어 31st December, 2025까지 지난 12개월 재무 결과에 영향을 미쳤습니다.이익 마진 증가: A219420는 과거에 흑자전환했습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: A219420의 수익은 지난 5년 동안 연평균 24.7% 감소했습니다.성장 가속화: A219420는 지난해 흑자전환하여 5년 평균과 수익 성장률을 비교하기 어렵습니다.수익 대 산업: A219420는 지난해 흑자전환하여 지난 해 수익 성장률을 IT 업계(6.8%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: A219420의 자본 수익률(5.9%)은 낮음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YSoftware 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/07 01:51종가2026/05/07 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Linkgenesis Co., Ltd.는 2명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Jongsun ParkEugene Investment & Securities Co Ltd.Hyun Dong LeeNH Investment & Securities Co., Ltd.
Reported Earnings • Mar 18Full year 2025 earnings released: EPS: ₩249 (vs ₩38.00 loss in FY 2024)Full year 2025 results: EPS: ₩249 (up from ₩38.00 loss in FY 2024). Revenue: ₩17.0b (up 30% from FY 2024). Net income: ₩2.80b (up ₩3.23b from FY 2024). Profit margin: 17% (up from net loss in FY 2024). Over the last 3 years on average, earnings per share has fallen by 54% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.
Reported Earnings • Nov 14Third quarter 2025 earnings released: EPS: ₩107 (vs ₩27.00 in 3Q 2024)Third quarter 2025 results: EPS: ₩107 (up from ₩27.00 in 3Q 2024). Revenue: ₩3.93b (up 64% from 3Q 2024). Net income: ₩1.21b (up 302% from 3Q 2024). Profit margin: 31% (up from 13% in 3Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.
Reported Earnings • Aug 16Second quarter 2025 earnings released: EPS: ₩51.00 (vs ₩60.00 in 2Q 2024)Second quarter 2025 results: EPS: ₩51.00 (down from ₩60.00 in 2Q 2024). Revenue: ₩3.45b (up 1.5% from 2Q 2024). Net income: ₩576.6m (down 15% from 2Q 2024). Profit margin: 17% (down from 20% in 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 73 percentage points per year, which is a significant difference in performance.
Reported Earnings • Mar 14Full year 2024 earnings released: ₩38.00 loss per share (vs ₩111 profit in FY 2023)Full year 2024 results: ₩38.00 loss per share (down from ₩111 profit in FY 2023). Revenue: ₩13.1b (down 7.7% from FY 2023). Net loss: ₩426.5m (down 134% from profit in FY 2023). Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.
Reported Earnings • Aug 15Second quarter 2024 earnings released: EPS: ₩60.00 (vs ₩92.00 in 2Q 2023)Second quarter 2024 results: EPS: ₩60.00 (down from ₩92.00 in 2Q 2023). Revenue: ₩3.40b (down 20% from 2Q 2023). Net income: ₩677.8m (down 34% from 2Q 2023). Profit margin: 20% (down from 24% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings.
Reported Earnings • Mar 16Full year 2023 earnings released: EPS: ₩111 (vs ₩172 in FY 2022)Full year 2023 results: EPS: ₩111 (down from ₩172 in FY 2022). Revenue: ₩14.2b (down 18% from FY 2022). Net income: ₩1.25b (down 35% from FY 2022). Profit margin: 8.8% (down from 11% in FY 2022). Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Reported Earnings • Mar 18Full year 2025 earnings released: EPS: ₩249 (vs ₩38.00 loss in FY 2024)Full year 2025 results: EPS: ₩249 (up from ₩38.00 loss in FY 2024). Revenue: ₩17.0b (up 30% from FY 2024). Net income: ₩2.80b (up ₩3.23b from FY 2024). Profit margin: 17% (up from net loss in FY 2024). Over the last 3 years on average, earnings per share has fallen by 54% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.
분석 기사 • Jan 02Capital Allocation Trends At Linkgenesis (KOSDAQ:219420) Aren't IdealWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...
Reported Earnings • Nov 14Third quarter 2025 earnings released: EPS: ₩107 (vs ₩27.00 in 3Q 2024)Third quarter 2025 results: EPS: ₩107 (up from ₩27.00 in 3Q 2024). Revenue: ₩3.93b (up 64% from 3Q 2024). Net income: ₩1.21b (up 302% from 3Q 2024). Profit margin: 31% (up from 13% in 3Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance.
Reported Earnings • Aug 16Second quarter 2025 earnings released: EPS: ₩51.00 (vs ₩60.00 in 2Q 2024)Second quarter 2025 results: EPS: ₩51.00 (down from ₩60.00 in 2Q 2024). Revenue: ₩3.45b (up 1.5% from 2Q 2024). Net income: ₩576.6m (down 15% from 2Q 2024). Profit margin: 17% (down from 20% in 2Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 73 percentage points per year, which is a significant difference in performance.
Buy Or Sell Opportunity • Apr 14Now 24% overvaluedOver the last 90 days, the stock has fallen 9.9% to ₩5,460. The fair value is estimated to be ₩4,411, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 6.5% over the last 3 years. Meanwhile, the company became loss making.
Buy Or Sell Opportunity • Mar 24Now 23% overvaluedOver the last 90 days, the stock has fallen 2.0% to ₩5,420. The fair value is estimated to be ₩4,414, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 6.5% over the last 3 years. Meanwhile, the company became loss making.
Reported Earnings • Mar 14Full year 2024 earnings released: ₩38.00 loss per share (vs ₩111 profit in FY 2023)Full year 2024 results: ₩38.00 loss per share (down from ₩111 profit in FY 2023). Revenue: ₩13.1b (down 7.7% from FY 2023). Net loss: ₩426.5m (down 134% from profit in FY 2023). Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.
공지 • Mar 01Linkgenesis Co., Ltd., Annual General Meeting, Mar 24, 2025Linkgenesis Co., Ltd., Annual General Meeting, Mar 24, 2025, at 10:00 Tokyo Standard Time. Location: conference room, 401, simin-daero, dongan-gu, gyeonggi-do, anyang South Korea
Buy Or Sell Opportunity • Jan 22Now 28% undervaluedOver the last 90 days, the stock has risen 72% to ₩7,370. The fair value is estimated to be ₩10,170, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 3.1% over the last 3 years. Earnings per share has declined by 43%.
분석 기사 • Jan 17Returns On Capital Signal Tricky Times Ahead For Linkgenesis (KOSDAQ:219420)If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
New Risk • Jan 16New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of South Korean stocks, typically moving 14% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (14% average weekly change). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.1% net profit margin). Market cap is less than US$100m (₩91.6b market cap, or US$62.8m).
New Risk • Dec 16New major risk - Financial data availabilityThe company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (₩67.3b market cap, or US$46.8m).
New Risk • Nov 26New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.1% net profit margin). Market cap is less than US$100m (₩67.4b market cap, or US$48.3m).
Reported Earnings • Aug 15Second quarter 2024 earnings released: EPS: ₩60.00 (vs ₩92.00 in 2Q 2023)Second quarter 2024 results: EPS: ₩60.00 (down from ₩92.00 in 2Q 2023). Revenue: ₩3.40b (down 20% from 2Q 2023). Net income: ₩677.8m (down 34% from 2Q 2023). Profit margin: 20% (down from 24% in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings.
분석 기사 • Aug 05Linkgenesis Co., Ltd.'s (KOSDAQ:219420) 26% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatioUnfortunately for some shareholders, the Linkgenesis Co., Ltd. ( KOSDAQ:219420 ) share price has dived 26% in the last...
Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 21%After last week's 21% share price decline to ₩4,510, the stock trades at a trailing P/E ratio of 56.3x. Average trailing P/E is 16x in the IT industry in South Korea. Total loss to shareholders of 59% over the past three years.
Buy Or Sell Opportunity • May 20Now 23% undervaluedOver the last 90 days, the stock has risen 4.4% to ₩7,770. The fair value is estimated to be ₩10,065, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 2.9% over the last 3 years. Earnings per share has declined by 15%.
New Risk • May 18New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 5.9% Last year net profit margin: 16% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.9% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (5.9% net profit margin). Market cap is less than US$100m (₩90.7b market cap, or US$67.0m).
Valuation Update With 7 Day Price Move • Mar 21Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩8,720, the stock trades at a trailing P/E ratio of 78.2x. Average trailing P/E is 18x in the IT industry in South Korea. Total returns to shareholders of 9.8% over the past three years.
Reported Earnings • Mar 16Full year 2023 earnings released: EPS: ₩111 (vs ₩172 in FY 2022)Full year 2023 results: EPS: ₩111 (down from ₩172 in FY 2022). Revenue: ₩14.2b (down 18% from FY 2022). Net income: ₩1.25b (down 35% from FY 2022). Profit margin: 8.8% (down from 11% in FY 2022). Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Feb 07Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩6,240, the stock trades at a trailing P/E ratio of 23.6x. Average trailing P/E is 20x in the IT industry in South Korea. Total loss to shareholders of 26% over the past three years.
Valuation Update With 7 Day Price Move • Dec 12Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₩6,890, the stock trades at a trailing P/E ratio of 26.1x. Average trailing P/E is 24x in the IT industry in South Korea. Total loss to shareholders of 2.1% over the past three years.
Valuation Update With 7 Day Price Move • Jul 26Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₩5,360, the stock trades at a trailing P/E ratio of 21.3x. Average trailing P/E is 17x in the IT industry in South Korea. Total loss to shareholders of 22% over the past three years.
Reported Earnings • Mar 18Full year 2022 earnings released: EPS: ₩172 (vs ₩394 in FY 2021)Full year 2022 results: EPS: ₩172 (down from ₩394 in FY 2021). Revenue: ₩17.3b (up 7.7% from FY 2021). Net income: ₩1.93b (down 53% from FY 2021). Profit margin: 11% (down from 26% in FY 2021). Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Sep 28Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₩5,300, the stock trades at a trailing P/E ratio of 20.9x. Average trailing P/E is 16x in the IT industry in South Korea. Total loss to shareholders of 36% over the past three years.
Valuation Update With 7 Day Price Move • Jun 17Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₩6,030, the stock trades at a trailing P/E ratio of 30.6x. Average trailing P/E is 15x in the IT industry in South Korea. Total loss to shareholders of 19% over the past three years.
Valuation Update With 7 Day Price Move • Mar 17Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₩8,580, the stock trades at a trailing P/E ratio of 41.9x. Average trailing P/E is 18x in the IT industry in South Korea. Total returns to shareholders of 27% over the past three years.
Valuation Update With 7 Day Price Move • Jul 30Investor sentiment improved over the past weekAfter last week's 16% share price gain to ₩10,150, the stock trades at a trailing P/E ratio of 40.5x. Average trailing P/E is 25x in the IT industry in South Korea. Total returns to shareholders of 18% over the past three years.
분석 기사 • Apr 07Linkgenesis (KOSDAQ:219420) Might Be Having Difficulty Using Its Capital EffectivelyDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things...
Reported Earnings • Mar 17Full year 2020 earnings released: EPS ₩55.00 (vs ₩59.00 in FY 2019)The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: ₩12.9b (up 13% from FY 2019). Net income: ₩722.2m (down 1.3% from FY 2019). Profit margin: 5.6% (down from 6.4% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.
분석 기사 • Mar 11Does Linkgenesis (KOSDAQ:219420) Have A Healthy Balance Sheet?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
분석 기사 • Feb 21Calculating The Fair Value Of Linkgenesis Co., Ltd. (KOSDAQ:219420)Does the February share price for Linkgenesis Co., Ltd. ( KOSDAQ:219420 ) reflect what it's really worth? Today, we...
분석 기사 • Feb 05Linkgenesis Co., Ltd.'s (KOSDAQ:219420) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?Linkgenesis (KOSDAQ:219420) has had a great run on the share market with its stock up by a significant 25% over the...
Is New 90 Day High Low • Feb 04New 90-day high: ₩8,620The company is up 23% from its price of ₩6,980 on 06 November 2020. The South Korean market is up 27% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the IT industry, which is up 13% over the same period.
분석 기사 • Jan 21What Type Of Returns Would Linkgenesis'(KOSDAQ:219420) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?Linkgenesis Co., Ltd. ( KOSDAQ:219420 ) shareholders should be happy to see the share price up 13% in the last month...
Is New 90 Day High Low • Jan 12New 90-day high: ₩8,220The company is up 2.0% from its price of ₩8,050 on 14 October 2020. The South Korean market is up 28% over the last 90 days, indicating the company underperformed over that time. It also underperformed the IT industry, which is up 18% over the same period.
분석 기사 • Jan 06Here's What To Make Of Linkgenesis' (KOSDAQ:219420) Returns On CapitalWhat trends should we look for it we want to identify stocks that can multiply in value over the long term? Typically...
분석 기사 • Dec 22Here's Why We Think Linkgenesis's (KOSDAQ:219420) Statutory Earnings Might Be ConservativeAs a general rule, we think profitable companies are less risky than companies that lose money. That said, the current...
분석 기사 • Dec 03Is Linkgenesis (KOSDAQ:219420) Using Too Much Debt?David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
분석 기사 • Nov 18Unpleasant Surprises Could Be In Store For Linkgenesis Co., Ltd.'s (KOSDAQ:219420) SharesWith a price-to-earnings (or "P/E") ratio of 50x Linkgenesis Co., Ltd. (KOSDAQ:219420) may be sending very bearish...
Reported Earnings • Nov 14Third quarter 2020 earnings released: EPS ₩59.00The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: ₩3.61b (up 78% from 3Q 2019). Net income: ₩582.5m (up ₩753.0m from 3Q 2019). Profit margin: 16% (up from net loss in 3Q 2019). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 74% per year but the company’s share price has increased by 22% per year, which means it is well ahead of earnings.